Clinical Trials Logo

Clinical Trial Summary

This study will be the first study that evaluates the effectiveness of antenatal corticosteroid (ACS) in late preterm twin neonates.


Clinical Trial Description

Antenatal corticosteroid (ACS) has been proven to prevent adverse outcomes including respiratory morbidities in preterm neonates before 34 weeks of gestations. Recently, it has been suggested that ACS may be also effective for reduction of respiratory complications in singleton late preterm pregnancies. On the contrary, there is a paucity of information regarding the effectiveness of ACS in twin neonates with late preterm birth, and nowadays guidelines are recommending the use of ACS in twin pregnancies based on the evidences in singleton pregnancies. However, the effect of ACS in twin needs to be determined, because the rate of neonatal morbidities in twin preterm neonates seems to be different from that in singleton neonates. This study aims to determine the effectiveness of ACS in late preterm twin neonates. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03547791
Study type Interventional
Source Seoul National University Hospital
Contact
Status Recruiting
Phase Phase 2/Phase 3
Start date May 5, 2018
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04773561 - Comparison of Posterior Ocular Changes Between Singleton Pregnancy and Multifetal Pregnancy. N/A
Recruiting NCT05773677 - Diet in Twin Pregnancy: the Wellness of Mother and Babies. N/A
Recruiting NCT06414655 - Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China
Terminated NCT02490384 - Physical Exam Indicated Cerclage in Twin Gestations N/A
Recruiting NCT04595214 - Develop a Multi-disciplinary Approach for a Personalized Prenatal Diagnostics and Care for Twin Pregnancies
Recruiting NCT05334264 - Prophylactic Cervical Cerclage in Twin Pregnancies With Non-shortened Cervix N/A
Completed NCT04055701 - Fetal Thymus Volume of Dichorionic Diamniotic Twin N/A